https://multiplesclerosisnewstoday.com/news-posts/2023/03/07/actrims-2023-vidofludimus-calcium-rrms-offers-safety-efficacy/
Immunic's novel RRMS treatment vidofludimus calcium may offer similar efficacy and better safety than approved MS therapies, new data shows.
Create an account or login to join the discussion